BaxterBaxter

Uniting to Save and Sustain Lives

Our Story

Baxter Our Story

Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of critical care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care.

For more than 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

Baxter Partnership with IRCAD and You

Baxter Our Story

Embracing a brighter future together, Baxter, with an extended surgical portfolio, through acquisition of Hillrom, is thrilled to partnership with IRCAD and you to Save and Sustain Lives in the operating room (OR).

Our aim is to foster a global community of OR professionals, collaborating and training to pioneer innovative surgical procedures and help ensure the best possible care for patients and healthcare professionals.

Let’s get together in our fully equipped OR at the IRCAD and shape the future of surgery.

Discover the Complete Surgical Ecosystem by Baxter

Every second around the world, caregivers enter the OR to save patients' lives. Discover how we're helping you make the most of every moment. From simple to complex procedures and from design to the final stage of construction. From today's devices to the solutions of tomorrow.

Set the stage for your new surgical suite: from the OR to ambulatory surgery centers, intensive care units and beyond.

Discover innovative tools and technologies. Let us help you creating foundations for surgical care.

Because the Future of Surgery Starts with You.
Baxter Gradient

Precision Positioning and Surgical Workflow

Surgical tables designed for easy setup and precise positioning, surgical lights that eliminate shadows, ceiling supply units providing workspace flexibility.

TS7000dV Surgical Table

TS7000dV Surgical Table

With Integrated Table Motion (ITM), the TS7000dV is the only surgical table that enables real-time patient repositioning for da Vinci Xi and dV5 robotic-assisted surgery.
HELUX PRO Surgical Light

HELUX PRO Surgical Light

Connects you to the future by providing OR Integration (ORI) compatibility, 4K imaging and improved patient safety features.
FCS 700 Ceiling Supply Unit

FCS 700 Ceiling Supply Unit

The FCS 700 pendant is designed to meet the needs of today’s ORs and ICUs while being flexible enough to adapt to evolving care settings.

Procedural Connectivity

Connects you to the future by providing OR Integration (ORI) compatibility, 4K imaging and improved patient safety features.

Baxter Procedural Connectivity

HELION Integrated Surgical System

Designed to help surgical teams simplify and facilitate video management, operations and workflows.

Surgical Hemostats, Sealants and Adhesion Barriers

Our leading portfolio of hemostats, sealants and adhesion barriers has been demonstrated to reduce intra- and post-operative complications, including those that require costly blood transfusions and extend operating time.1-3 Fewer complications often translate into faster recovery for your patients and greater cost efficiencies for your hospital or clinic.

HEMOPATCH Sealing Hemostat

HEMOPATCH Sealing Hemostat

Hemopatch sealing hemostat provides secure, sustained sealing with rapid, reliable control of bleeding and leakage.1,4-7
FLOSEAL Hemostatic Matrix

FLOSEAL Hemostatic Matrix

From routine haemostasis to unexpected bleeds, surgeons around the world trust Floseal haemostatic matrix to stop various bleeding grades.8
TISSEEL Fibrin Sealant

TISSEEL Fibrin Sealant

Tisseel is the only fibrin sealant that has haemostasis, sealing and tissue adherence indications, with 40 years of clinical research supporting its use.9-10
SEPRAFILM Adhesion Barrier

SEPRAFILM Adhesion Barrier

Seprafilm is an adhesion barrier that reduces the incidence, extent and severity of adhesions following abdominopelvic surgery.11

Our Experience in the OR

  • +1,400

    INTEGRATED SURGICAL TABLES DELIVERED

  • +1,100

    FACILITIES WITH CONNECTED ORs

  • +800

    ORs WITH VIDEO INTEGRATION

  • +500,000

    PATIENTS ARE BEING TREATED WITH HEMOSTATS AND SEALANTS EVERY YEAR

Let's Look to the Future Together

Connect with us to discuss your the future of care in your Operating Rooms and how we can assist.

This form is provided by Baxter. By enabling it, your data will be sent directly to them :

This site is intended for Healthcare Professionals.

For safe and proper use of the product mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.

These medical devices are a regulated health product which, pursuant to such regulation, bears a CE mark. Baxter recommends that you carefully read the detailed instructions for safe and proper use included in the documents accompanying the medical devices.

The personnel of healthcare establishments are responsible for the proper use and maintenance of this medical device.

Baxter, FCS 700, Floseal, Helion, Helux Pro, Hemopatch, Hillrom, Seprafilm, Tisseel and TS7000dV are trademarks of Baxter International Inc. or its subsidiaries.

Any other trademarks, product names or brand images appearing herein are the property of their respective owners.

Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported to Complaints_Intake_EMEA@baxter.com.

Adverse Events should be reported to Baxter by email vigilanceuk@baxter.com.

Drug or medical device product quality complaints relating to Baxter products can be reported by email directly to Complaints_Intake_EMEA@baxter.com.

  1. Lewis KM, Ikeme S, Olubunmi T, et al. Clinical effectiveness and versatility of a sealing hemostatic patch (Hemopatch) in multiple surgical specialties. Exp Rev Med Dev. 2018;15:367-376.

  2. Weltert L, et al. Prospective randomized clinical trial of Hemopatch topical sealant in cardiac surgery. Surg Tech Intl. 2016;29: sti29-756. 5.

  3. Ikeme S, et al. Cost-effectiveness analysis of a sealing hemostat patch (Hemopatch) vs standard of care in cardiac surgery. J Med Econ. 2018;21(3):273-281.

  4. HEMOPATCH Sealing Hemostat Instructions for Use. 09/2024

  5. Technical Report: Hemopatch Sealing Hemostat Room Termperature Configuration. Study Number BXU613308. [Baxter Data on File]. December 18, 2024

  6. Lewis KM, Ikeme S, Olubunmi T, et al. Clinical effectiveness and versatility of a sealing hemostatic patch (Hemopatch) in multiple surgical specialties. Exp Rev Med Dev. 2018;15:367-376.

  7. Lombardo C, Lopez-Ben S, Boggi U, et al. Hemopatch is effective and safe to use: real-world data from a prospective European registry study. Updates Surg. 2022;74:1521-1531.

  8. FLOSEAL Haemostatic Matrix. Instructions for Use 10/2024

  9. TISSEEL [Fibrin Sealant] full Prescribing Information: July 2020

  10. Baxter Data on File: Embase (1974-11/15/2019) and MEDLINE (1946 - week 2 in 11/2019) database searches

  11. SEPRAFILM Adhesion Barrier Instructions for Use 09/2021

  • Composition: prefilled double chamber syringe containing deep frozen Sealer Protein Solution (with aprotinin) and Thrombin Solution (with Calcium Chloride Dihydrate). Sealer Protein Solution contains 91mg/ml human fibrinogen (clottable protein) and 3000 KIU/ml aprotinin. Thrombin Solution contains 500 IU/ml human thrombin and 40μmol per ml calcium chloride. Presentations of 1, 2 or 5ml in each chamber resulting in total volume of 2ml, 4ml or 10ml of sealant.

  • Indications: Supportive treatment where standard surgical techniques are insufficient, for improvement of haemostasis, as a tissue glue to promote adhesion, sealing or as suture support, in gastrointestinal anastomoses, in neurosurgery where contact with cerebrospinal fluid or dura mater may occur and for mesh fixation in hernia repair, as an alternative or adjunct to sutures or staples. Dosage and Route: For epilesional (topical) use only. Use of TISSEEL is restricted to experienced surgeons who have been trained in the use of TISSEEL. A thin layer is applied under direct vision to the tissue surface where required. Dose depends on the indication, application method and number of applications. For tissue adherence, it is recommended that the initial application cover the entire intended application area. As a guideline for the gluing of surfaces, 1 pack of TISSEEL 2 ml will be sufficient for an area of at least 10 cm2. Tissue surface should be as dry as possible before application. Do not use pressurized air or gas for drying the site. Application can be repeated if necessary but avoid reapplication of TISSEEL to pre-existing polymerized TISSEEL. Apply by drops or spray as needed depending on indication. Side effects: See Summary of Product Characteristics for detail. Postoperative wound infections. Fibrin degradation products increased. Hypersensitivity/anaphylactic reactions, anaphylactic shock, paresthesia, bronchospasm, wheezing, pruritus, erythema. Sensory disturbance. Bradycardia, tachycardia. Axillary vein thrombosis, hypotension, haematoma, embolism arterial, air embolism, cerebral artery embolism, cerebral infarction. Dyspnoea. Nausea, Intestinal obstruction. Rash, urticaria, impaired healing. Pain in an extremity. Procedural pain, pain, increased body temperature, flushing, oedema. Seroma, angioedema. Class reaction: Air or gas embolism, see Precautions.

  • Precautions: Life threatening thromboembolic complications may occur if unintentionally applied intravascularly. Apply with care in coronary artery bypass surgery due to increased risk of inadvertent intravascular application. Must not be injected into highly vascularized tissue, such as nasal mucosa. When spraying TISSEEL, changes in blood pressure, pulse, oxygen saturation and end tidal CO2 should be monitored because of the possibility of occurrence of air or gas embolism. Air or gas embolism, tissue rupture, or gas entrapment with compression, which may be life-threatening, have occurred with the use of spray devices employing a pressure regulator to administer fibrin sealant at higher than recommended pressures and in close proximity to the tissue surface. When applying by spray, follow the instructions provided with the spray device, with particular reference to gas pressure and distance from the tissue surface. Do not administer with spray devices in enclosed body areas. Take risk of compressive complications into account when applying in confined spaces. Use with caution in patients with prior exposure to aprotinin. Caution in patients with bovine protein allergies. Infectious diseases due to the transmission of infective agents cannot be totally excluded. Use of Tisseel and batch number should be recorded in patient's notes. Excessive clot thickness may negatively interfere with product efficacy and the healing process. Oxidised cellulose- containing preparations should not be used with TISSEEL.

  • Contraindications: Do not apply intravascularly. Hypersensitivity to active substances or other components. Not for the treatment of active or spurting arterial or venous bleeding. Not for replacement of skin sutures intended to close surgical wounds. Interactions: Avoid solutions containing alcohol, iodine and heavy metals.

  • Overdose: Not reported.

EMA-CS84-250006 (v1.0) 07/2025